GMVD - G MEDICAL INNOVATIONS WILL PROVIDE SERVICES TO VETERANS AND MILITARY PERSONNEL BY PARTNERING WITH RESILIENT SUPPORT SERVICES
(NewsDirect)
Rehovot, Israel,August 17 th , 2023 – G Medical Innovations Holdings Ltd.(Nasdaq: GMVD) (“G Medical Innovations”), an industry innovator incomprehensive remote patient monitoring solutions, today announcedthat its wholly-owned subsidiary, G Medical Innovations USA, Inc., hasentered into an agreement with Resilient Support Services Inc.(“RSS”) to expand the health care and remote patient monitoringcapabilities to U.S. veterans and military personnel. RSS is aService-Disabled Veteran-Owned Business that partners with U.S.federal agencies and private sector businesses that are concerned withimproving the medical care of veterans and the military community.
G Medical Innovations’innovative technology will help federal agencies and militarypersonnel to better monitor and diagnose new onset cardiovascularsymptoms as part of a growing need in virtual care. This will allowfull access to near real-time patient information which will also beanalyzed by certified cardiac monitoring technicians through G MedicalInnovations’ own independent diagnostic testing facility. Availableto both adult and pediatric patients, this cloud-based monitoringsystem includes a small, water-resistant monitor that patients willreceive by mail or in person. Patient’s symptoms can then bemonitored in near real-time from the comfort of their home. Those whoexperience unusual arrhythmias or other monitored symptoms receiveimmediate communication from providers, enabling greater access tocare and, in some cases, earlier diagnoses of serious medicalconditions.
The use of the GMedical Prizma device will allow for state-of-the-art remote patientmonitoring (RPM) in the comfort of their home. This care experienceplatform ensures that patients remain connected with their care teamsthrough next-generation devices to improve clinical decision-making.The patients will be able to download the G Medical app and receive adigital health kit to measure biometric data in one single device.
“We are excited tohave G Medical Innovations provide their powerful technology and 31test kits to those serving our country in veteran affairs and allmilitary branches here and abroad. Innovations like this will helpprotect and improve the care of our veterans and military servingsoldiers, now and into the future,” explained Robert Domenici,Lieutenant Colonel (USA Ret.) President and CEO, RSS Inc.
“We are delighted tosay that we could not find a better partner to serve veterans affairsand all military branches than RSS Inc. G Medical is committed toproviding the highest level of care and service to our veterans andmilitary personnel,” said Dr. Yacov Geva, Chief Executive Officerand Founder of G Medical Innovations.
About G MedicalInnovations
G MedicalInnovations is a healthcare company engaged in the development of nextgeneration mHealth and telemedicine solutions and monitoring serviceplatforms. The Company’s solutions and services can empowerconsumers, patients, and providers to better monitor, manage andimprove clinical and personal health outcomes, especially for thosewho suffer from cardiovascular disease, pulmonary disease, anddiabetes. The Company’s current product lines consist of its Prizmamedical device, a clinical-grade device that can transform almost anysmartphone into a medical monitoring device, enabling both healthcareproviders and individuals to monitor, manage and share a wide range ofvital signs and biometric indicators; its Extended Holter andMonitoring Cardiac Telemetry Patch services, utilizing multi-channelpatient-worn biosensors with algorithms, to generate real timeanalysis and transmission that captures electrocardiography datacontinuously, including QT syndrome prolongation detection. Inaddition, the Company is developing its wireless vital signsmonitoring system, which is expected to provide full, continuous, andreal-time monitoring of a wide range of vital signs and biometrics.Its monitoring services include provision of independent diagnostictesting facility monitoring services and private monitoring services.
For more informationabout G Medical innovations, visit https://gmedinnovations.com/ .
About ResilientSupport Services
Resilient Support Services Inc. (RSS Inc.) is an experiencedmulti-faceted certified service-disabled veteran-owned businessproviding strategic advisory services to companies looking tonavigate, identify and capitalize on the vast procurement complexitiesand opportunities within the federal, state, local government and thecommercial sectors. The company has a wide-array of health/safety,defense, industrial supply and construction products and serviceofferings available to its government and commercial clients withinthe US and abroad.
Forward-Looking Statements
This press release contains forward-looking statements withinthe meaning of the “safe harbor” provisions of the PrivateSecurities Litigation Reform Act of 1995 and other Federal securitieslaws. Words such as “expects,” “anticipates,” “intends,”“plans,” “believes,” “seeks,” “estimates,” and similarexpressions or variations of such words are intended to identifyforward-looking statements. For example, G Medical Innovations isusing forward-looking statements when it discusses the services andproducts to be provided by the Company to Resilient Support ServicesInc and the potential benefits of G Medical Innovations’ technologyand specifically the G Medical Prizma device to end users. Becausesuch statements deal with future events and are based on theCompany’s current expectations, they are subject to various risksand uncertainties, and actual results, performance, or achievements ofG Medical Innovations could differ materially from those described inor implied by the statements in this press release. Theforward-looking statements contained or implied in this press releaseare subject to other risks and uncertainties, including thosediscussed under the heading “Risk Factors” in G Medical’sInnovations Annual Report on Form 20-F for the year ended December 31,2022, filed with the Securities and Exchange Commission (“SEC”) onMay 16, 2023, and our other filings with the SEC, which are availableon the SEC’s website, www.sec.gov .Except as otherwise required by law, G Medical Innovations undertakesno obligation to publicly release any revisions to theseforward-looking statements to reflect events or circumstances afterthe date hereof or to reflect the occurrence of unanticipated events.References and links to websites have been provided as a convenience,and the information contained on such websites is not incorporated byreference into this press release.
Investor Relations Contact
G Medical Innovations
service@gmedinnovations.com
G MedicalInnovations Holdings Ltd. is a health care company engaged in thedevelopment of next generation mHealth and telemedicine solutions andmonitoring service platforms. The Company’s solutions and servicescan empower consumers, patients, and providers to better monitor,manage and improve clinical and personal health outcomes, especiallyfor those who suffer from cardiovascular disease, pulmonary disease,and diabetes. The Company’s current product lines consist of itsPrizma medical device, a clinical-grade device that can transformalmost any smartphone into a medical monitoring device, enabling bothhealth care providers and individuals to monitor, manage and share awide range of vital signs and biometric indicators; its ExtendedHolter and Monitoring Cardiac Telemetry Patch services, utilizingmulti-channel patient-worn biosensors with algorithms, to generatereal time analysis and transmission that captures electrocardiographydata continuously, including QT syndrome prolongation detection. Inaddition, the Company is developing its wireless vital signsmonitoring system, which is expected to provide full, continuous, andreal-time monitoring of a wide range of vital signs and biometrics.Its monitoring services include provision of independent diagnostictesting facility monitoring services and private monitoringservices.
This press release contains forward-looking statementswithin the meaning of the “safe harbor” provisions of the PrivateSecurities Litigation Reform Act of 1995 and other Federal securitieslaws. Words such as “expects,” “anticipates,” “intends,”“plans,” “believes,” “seeks,” “estimates,” and similarexpressions or variations of such words are intended to identifyforward-looking statements. For example, G Medical Innovations isusing forward-looking statements when it discusses: revenue growth andprofitability in future periods; the launch of the Company’s CLIAlab in Austin, TX, the Company’s online store for its PrizmaMonitoring Devices on Amazon Marketplace and the Company’s HTKsbusiness and online stores; potential announcements with largehomecare service companies and large distributors for devices and AtHome Test Kits; and the Company’s plans to expand its line ofmonitoring products and services offered to patients, hospitals andclinics. Because such statements deal with future events and are basedon the Company’s current expectations, they are subject to variousrisks and uncertainties, and actual results, performance, orachievements of G Medical Innovations could differ materially fromthose described in or implied by the statements in this press release.The forward-looking statements contained or implied in this pressrelease are subject to other risks and uncertainties,, includingthose discussed under the heading “Risk Factors” in G Medical’sInnovations Annual Report on Form 20-F for the year ended December 31,2022, filed with the Securities and Exchange Commission (“SEC”) onMay 16, 2023, and our other filings with the SEC, which are availableon the SEC’s website, www.sec.gov. Except as otherwise required bylaw, G Medical Innovations undertakes no obligation to publiclyrelease any revisions to these forward-looking statements to reflectevents or circumstances after the date hereof or to reflect theoccurrence of unanticipated events. References and links to websiteshave been provided as a convenience, and the information contained onsuch websites is not incorporated by reference into this pressrelease.
Contact Details
G MedicalInnovations
G Medical Innovations
+9728-958-4777
CompanyWebsite
Copyright (c) 2023 TheNewswire - All rights reserved.